Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey Sharpei, been a long time. Hope you’ve been well!
Welcome back.
And probably an approval of the dopamine agonist in October? Filed 12/22/22 or thereabouts. Not a needle mover but every bit helps.
My guess would be if approved in Oct/Nov 2023, maybe launch in Jan/Feb 2024?
https://elite.irpass.com/Elite-Pharmaceuticals-Files-ANDA-with-US-FDA-to-Market-Dopamine-Agonist-12-22-2022
Holy shit this volume lol
Didn’t we have like 90k volume total on some days in the past?
Kcidstae calling in all the reserves huh, five alarm fire in the boiler
Agreed. Idea behind the buyback was reduce the OS and improve the stock performance from all-time-lows.
If that happens organically as it seems to be now? Then so be it.
Think it was just the lull we had to get through as they pivoted from full-bore ART to building the full pipeline of generics at all stages of the approval process. Now finally seeing the blooming of the planted seeds.
Still don’t think the stock was ever truly “worth” as low as mid 2s, should’ve been higher all along.
Welcome aboard the positive train!!!!!!!
:)
Same. ;(
Hahahah scramble!!! Call in reinforcements!!
Impotent
Nothing to save, hundreds of thousands of shares been on lock for awhile. News flash - you can be both a long term holder and trade a portion of your holdings.
But simpletons can’t hold two ideas in their head simultaneously I guess.
Impotent
So now your preferred line of attack is “haha, you so dumb, stock went up” ? That’s really what you’re sticking with?
Hahahahahahhaah
…..
Ahahahahahah!
Same. Boiler room is absolutely seething though.
Reached their boiling point, one might say.
Hahahah. Attempts getting more feeble by the day.
Even impotent, one might say.
Pathetic.
Jury is still out on that. They did announce results from a trial earlier in the year:
https://finance.yahoo.com/news/elite-pharmaceuticals-reports-positive-results-120000237.html
But then they didn’t for strategic reasons after the Oxycodone insufflation study.
CEO on record on most recent call stating that they’ll announce filings and approvals (and product launches of course).
We’ll see.
Pretty measured post, I’d concur. .10 - .20 over the next year sure seems doable with what we now know.
Oxy announcement/approval over the next year
Same with needle mover #2
Maybe #3 gets filed first half of 2024?
Prasco deal in January
Dexcel/other foreign deals as the wildcard
Maybe not a huge impact but sounds like Kirko is also growing our smaller products as well under our own label.
And Nasrat also mentioned being willing to sell other companies’ drugs.
Divert, deflect, dip, duck, dive, dodge - anything to get off the topic of the company and stock succeeding. LOL.
Is your cube near a window with a view at least?
Slob prob gets paid in cheeseburgers
Hahaha stock was less than 3 cents, now it’s around 6 cents and the best you can do now in the face of the stock doubling in value is obsessing over one of my individual trades, and you can’t even get that one right.
LOL. Honk honk.
Plenty of patience.
Think I give a damn? Profited off that trade tax free but thanks for asking.
Weak reply but that’s to be expected, not much left to gripe about.
Stick around though, can’t wait to see what the next angle is. Honk honk.
Maybe.
We know at a minimum that they have enough faith in Elite’s manufacturing capabilities to have Elite start providing them the authorized generic product for Adderrall ER next year.
A good several days. Definitely a welcome change in overall trend/sentiment. Lots to look forward to.
He can answer of course - my guess is he’s basing it off a certain revenue number.
For historical comparison, I think Epic (company we were partnered with) was making around $100M in revenues annually when they were acquired by Humanwell for a $550M purchase price.
https://www.genengnews.com/news/humanwell-puracap-acquire-epic-pharma-for-550m/
You are correct. I sold some trading shares. I bought them back and some, kept majority of the profit. Slightly higher cost basis. Not mad about it.
So does Elite, or Prasco, go back to the DEA and basically say “hey, look at our new contract for this authorized generic supplier, allot Elite more quota please” ?
Wondering how Elite obtains the API necessary to keep selling and growing their own market share + supplying additional product to Prasco as well.
Harder and harder to fight the positive momentum here, totally get it. The antics are growing more and more desperate, it’s a beauty to watch.
Whiners, man
“I’m so tired of idiots.”
Same. Particularly ones who cry daily about selling the company at 15 cents/share.
I’ll chip in if you’re short
Good point.
Unknowns will always exist.
I’m glad we agree that Elite is substantially less risky and in a much stronger position than in years past.
Hell yeah, cheers. He did seem to be on point and outlined many potential upcoming catalysts.
Agree on Oxy. I hope we are first to file and able to launch it relatively soon after approval.
Shouldn’t you be happy about the solid call and the solid quarter results? Lol.
I think you’re conflating missed goals like Nasdaq and nefarious intent re: hostile takeover of the company. I’m saying regardless of what you believe his intent actually is, the logic simply doesn’t follow. If he wanted to take it private, he could’ve done so long ago and wouldn’t have spent the time, money, and effort to make the company more valuable. Just doesn’t make sense.
“The Company also submitted partial ANDA for pain management for FDA review. The partial application contained the recently concluded insufflation study. Elite received correspondence from FDA requesting certain information.
**The information has been gathered and the response will be out to FDA this week.** **This is one of the three needle mover products that I spoke of six weeks ago.** Elite has another product that is undergoing a pivotal DE clinical trial. If we pass then we expect to file this ANDA this year. **Just to make sure that everybody understands me, two of the three needle mover ANDAs as I spoke of will be filed this year.”**
So call it Friday, 8/18 to be safe? Should expect the Oxy generic announcement from Elite after hearing back from the FDA (45-60 days), puts it roughly somewhere between 10/2/23 - 10/17/23, assuming no more data requests.
2 of 3 needle mover filings to be completed by EOY. Nasrat also confirmed that the needle movers are all in either pain management or stimulant categories and 2 of the 3 may be bigger than our Adderralls.
“But all evidence right now shows that these products will be as big, if not bigger than Adderall IR and ER at least two of the three.”
Lmao. He picked it apart and I’m glad, that’s why I sent the question. He said essentially what I already said here before - why spend so much time and energy growing the company when you could do the opposite, sabotage it and take it over cheap? The logic just doesn’t follow.
Also good that he acknowledged buybacks are “on the table”, just undoubtedly down the road a bit.
Sure chief, see ya tomorrow.
“I never doubted their effort and results.”
LOL. Little historical revisionism there, eh??